Wordt geladen...
HER2-Amplified Salivary Duct Carcinoma: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment
BACKGROUND: Salivary ductal carcinoma is a rare cancer with poor prognosis and limited treatment options. HER2-directed treatment has been attempted in HER2-amplified or overexpressed salivary gland malignancies with limited success. METHODS: We report resolution of measurable disease and minimal re...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3893310/ https://ncbi.nlm.nih.gov/pubmed/23852769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.23429 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|